Donald R O'Boyle

Title: Innovations by Donald R O'Boyle

Introduction

Donald R O'Boyle is a notable inventor based in Clinton, CT (US). He has made significant contributions to the field of medical research, particularly in the development of assays for Hepatitis C virus (HCV). With a total of 2 patents, his work has the potential to impact the treatment of this viral infection.

Latest Patents

One of his latest patents focuses on Hepatitis C virus assays. This invention includes an assay useful for identifying inhibitors of HCV activity. It is directed to a dual HCV assay that quantifies both the amount of HCV RNA replication inhibitory activity associated with a test compound and the amount of cytotoxicity associated with that compound. Additionally, this patent encompasses compounds discovered using this assay, compositions containing such compounds, and methods of treating Hepatitis C through the administration of these compounds. Another significant patent involves Iminothiazolidinones as inhibitors of HCV replication. This patent describes compounds that can inhibit HCV replication, particularly the function of the HCV NS5A protein.

Career Highlights

Donald R O'Boyle is associated with Bristol-Myers Squibb Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and treatment of Hepatitis C.

Collaborations

He has collaborated with Julie A Lemm, enhancing the research efforts in their field.

Conclusion

Donald R O'Boyle's innovative work in the development of assays for Hepatitis C virus demonstrates his commitment to advancing medical research. His contributions are vital in the ongoing fight against viral infections.